Breaking News
Subscribe Now 0
📈 69% of S&P 500 stocks beating the index - a historic record! Pick the best ones with AI. See top stocks
Close

Lavipharm SA (LPHr)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
0.7790 -0.0020    0.00%
16:34:59 - Closed. Currency in EUR ( Disclaimer )
Type:  Equity
Market:  Greece
ISIN:  GRS246003008 
  • Volume: 41,117
  • Bid/Ask: 0.7790 / 0.7790
  • Day's Range: 0.7770 - 0.7840
Lavipharm SA 0.7790 -0.0020 0.00%

Lavipharm SA Company Profile

 
Get an in-depth profile of Lavipharm SA, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryPharmaceuticals
SectorHealthcare
Employees

285

Equity Type

ORD

Lavipharm S.A. engages in the research, development, manufacture, import, marketing, sale, and wholesale of pharmaceutical, dermocosmetic, and healthcare products to physicians and pharmacists in Greece and internationally. The company offers pharmaceutical products for cardiology, oncology-urology, central nervous system, chronic pain, and self- treatment. It also provides prescription medicines and over the counter (OTC) products, as well as LIFELAB CBD. The company was founded in 1911 and is based in Paiania, Greece.

Contact Information

Address 12, Agias Marinas Street PO Box 59
Paiania, 190 02
Greece
Phone 30 210 66 91 000
Fax 30 210 66 91 119

Top Executives

Name Age Since Title
Minas G. Tanes 83 2021 Chairman of the Board
Venetsiana-Loukia Lavida - - Vice President of the Board
Sophia Kounenaki-Efraimoglou - 2019 Independent Non Executive Director
James Christopoulos - - Independent Non Executive Director
Christos Diamandopoulos - - Non Executive Director
Vicky D. Kefalas 54 2023 Independent Non-Executive Board Member
Telemaque Jean Lavidas - 2019 Executive Board Member
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

LPHr Comments

Write your thoughts about Lavipharm SA
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Apple
Continue with Google
or
Sign up with Email